000 01607 a2200433 4500
005 20250516034043.0
264 0 _c20111110
008 201111s 0 0 eng d
022 _a1469-5111
024 7 _a10.1017/S1461145711000642
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevkovitz, Yechiel
245 0 0 _aDeep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
_h[electronic resource]
260 _bThe international journal of neuropsychopharmacology
_cAug 2011
300 _a991-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aCognition Disorders
_xcomplications
650 0 4 _aCombined Modality Therapy
_xinstrumentation
650 0 4 _aFeasibility Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuropsychological Tests
650 0 4 _aPrefrontal Cortex
_xphysiology
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aSchizophrenia
_xcomplications
650 0 4 _aSchizophrenic Psychology
650 0 4 _aTranscranial Magnetic Stimulation
_xadverse effects
700 1 _aRabany, Liron
700 1 _aHarel, Eiran Vadim
700 1 _aZangen, Abraham
773 0 _tThe international journal of neuropsychopharmacology
_gvol. 14
_gno. 7
_gp. 991-6
856 4 0 _uhttps://doi.org/10.1017/S1461145711000642
_zAvailable from publisher's website
999 _c20789048
_d20789048